An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non–small-cell lung cancer.
Dissemination of non–small-cell lung cancer (NSCLC) in the central nervous system is a frequent and challenging clinical problem. Systemic or local therapies rarely prolong survival and have modest activity regarding local control. Alterations in gene expression in brain metastasis versus primary tu...
| Published in: | European Journal of Cancer Vol. 132; pp. 24 - 35 |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | research tables/charts Journal Article |
| Published: |
Pergamon Press - An Imprint of Elsevier Science
Jun2020
|
| Online Access: | View this record in EBSCOhost |